Verily, Alphabet's life sciences company, is adapting its Project Baseline study to also examine how the immune system reacts to SARS-CoV-2 infections, CNBC reports.
Verily launched Project Baseline in 2017. The project aimed to analyze genetic data, blood samples, imaging, and more from 10,000 volunteers to get a sense of what a healthy person looks like.